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The chHES-427 cell linewas derived fromabnormal embryo carrying
the pathogenic mutant of SMN gene donated by spinal muscular atro-
phy (SMA) carriers after preimplantation genetic diagnosis (PGD) treat-
ment. PCR-RFLP analysis conﬁrmed that the chHES-427 cells carried the
homozygous deletion of exon 7 of SMN1 which was the most commond Stem Cell Engineering, School
ha, China.
. This is an open access article undermutation among the SMA patients (Fig. 1A). The karyotype analysis of
the chHES-427 cells showed a stable Karyotype of 46, XX during
prolonged culture (Fig. 1B).
The undifferentiated chHES-427 cells expressed the pluripotency
related genes such asNANOG, POU5F1, SOX2, KLF4, TERF1 and THY1 de-
tected by RT-PCR (Fig. 2A). More than 90% of the cells were positive for
NANOG assessed by FACS analysis (Fig. 2B). The cells also expressed the
pluripotentmarkers TRA-1-81, TRA-1-60, POU5F1, NANOG and alkaline
phosphatase (Fig. 2C). The differentiation capability was demonstrated
by embryoid body (EB) formation in vitro. The immunocytochemistry
analysis proved that the EB derivatives came from the three germ layers
(ectoderm: TUJ1; mesoderm: SMA; endoderm: AFP) (Fig. 3).
Materials and methods
Source of embryo
This research was approved by the ethical committee of Reproduc-
tive and Genetic Hospital of CITIC-Xiangya. Abnormal embryos with
aberrant mutant of SMN genewere donated by a couple of SMA carriers
after signed informed consent. These embryoswere cultured in G-series
sequentialmedium (G1 andG2, Vitrolife) to the blastocyst stage at 37 °C
in 5% CO2, 5% O2 and 90% N2 with 95% humidity.
hESC line derivation and cell culture
The cell line chHES-427 was derived from the inner cell mass (ICM)
of the blastocyst carrying SMNmutant. The methodology used for hESC
line derivation was performed as previously described (Lin et al., 2009).
In brief, the ICM was mechanically isolated and plated on mitoticallythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Genetic diagnosis and the karyotype of chHES-427 cell line. (A) Homozygous deletion of SMN1 assessed by PCR-RFLP. The chHES-427 cells (Column 1) exhibited only one band of
156 bp, resemble the positive control (Column 3) from a SMA patient, indicating the homozygous deletion of SMN1 exon 7. The wild-type samples (Column 2) exhibited two bands of
189 bp and 156 bp, indicating no deletion or a heterozygous deletion of SMN1 exon 7. Column 4 was a blank control. Column M represented 50 bp ladder marker. (B) chHES-427 had
a normal karyotype 46, XX.
Fig. 2. Characterization of pluripotency of chHES-427 cell line. (A) Expression of pluripotency related genes by RT-PCR. Genes such as NANOG, POU5F1, SOX2, KLF4, TERF1 and THY1were
detected in the undifferentiated cells. (B) FACS analysis demonstrated the presence of high levels of NANOG (90.9%). Blue histograms represent isotype controls. (C) chHES-427 colonies
were positive for pluripotent markers: NANOG, POU5F1, TRA-1-81, TRA-1-61 and AKP. Scale bar =100 μm.
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Fig. 3. In vitro differentiation of the chHES-427 cells. Derivatives from embryoid bodies were positive for three germ layers markers: TUJ1, SMA and AFP. Scale bar =50 μm.
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in ES medium comprising of 15% knockout serum replacement,
2 mM L-glutamine, 2 mM nonessential amino acids, 0.1 mM β-
mercaptoethanol and 4 ng/mL of basic Fibroblast Growth Factor
(bFGF) (all from Invitrogen). Undifferentiated cell colonies were
passaged mechanically per week for long-term culture.
Mutation veriﬁcation
Genomic DNAwas extracted usingQIAmp®DNAmini kit (QIAGEN).
Deletion of exon 7 of SMN1 gene was examined by PCR ampliﬁcation
followed by restriction endonuclease digestion according to themethod
mentioned previously (Van der Steege et al., 1995). PCRwas performed
in a 20 μL ampliﬁcation reaction mixture containing 80 ng DNA, 1.0 μM
of each primer (the forward primer: 5′-AGACTATCAACTTAATTTCTGA
TCA-3′ and the reverse primer: 5′-CCTTCCTTCTTTTTGATTTTGTTT-3′)
and 10 μL of 2 × GreenMaster Mix (Promega). Cycling conditions were
as follows: 95 °C for 1.5 min followed by 35 cycles of ampliﬁcation
(95 °C denaturation for 40 s, 56 °C annealing for 40 s, 72 °C elongation
for 40 s) and a ﬁnal extension at 72 °C for 5 min. The PCR products
were digested with Dra I (Fermentas). The restriction pattern of the
PCR products was evaluated using 8% PAGE and visualized by silver
staining.
RT-PCR
Total RNA was extracted with TRIzol (Invitrogen) and reverse tran-
scriptionwas performed using Transcriptor First Strand cDNA Synthesis
kit (Roche) according to the manufacturer's instructions. The thermal
cycling conditions were 95 °C for 2 min, followed by 32 cycles of ampli-
ﬁcation (95 °C for 30 s, 54–64 °C for 30 s and 72 °C for 30 s) as well as a
ﬁnal extension at 72 °C for 5 min. The PCR products were separated
on 2% agarose gel by electrophoresis and visualized on a UVTable 1
List of primers used in RT-PCR.
Genes Primer sequence Temp.
(°C)
Product size
(bp)
POU5F1 5′-AGCGAACCAGTATCGAGAAC-3′ 54 142
5′-TTACAGAACCACACTCGGAC-3′
KLF4 5′-TCTCAAGGCACACCTGCGAA-3′ 55 105
5′-TAGTGCCTGGTCAGTTCATC-3′
NANOG 5′-TGAACCTCAGCTACAAACAG-3′ 52 154
5′-TGGTGGTAGGAAGAGTAAAG-3′
SOX2 5′-AGCTACAGCATGATGCAGGA-3′ 55 126
5′-GGTCATGGAGTTGTACTGCA-3′
TERF1 5′-GCAACAGCGCAGAGGCTATTATT-3′ 58 160
5′-AGGGCTGATTCCAAGGGTGTAA-3′
THY1 5′-AGAATACCAGCAGTTCACCCATCC-3′ 58 293
5′-CCTCACACTTGACCAGTTTGTCTCTG-3′
β-ACTIN 5′-TCCCTGGAGAAGAGCTACGA-3′ 57 194
5′-AGCACTGTGTTGGCGTACAG-3′transluminator. The product sizes, annealing temperatures and primer
sequence are listed in Table 1.
Immunocytochemistry and alkaline phosphatase staining
Undifferentiated hESC colonies and derivatives from embryoid
bodies were ﬁxed in 4% Paraformaldehyde, permeabilized with 0.2%
TritonX-100 and blocked with 10% donkey serum in PBS. Then samples
were stained with the following primary antibodies: mouse anti-
POU5F1 (1:200, Santa Cruz), rabbit anti-NANOG (1:50, Abcam),
mouse anti-TRA-1-81 (1:50, Millipore), mouse anti-TRA-1-60 (1:50,
Millipore), mouse anti-TUJ1 (1:400,Sigma), mouse anti-AFP (1:500,
Sigma) andmouse anti-SMA (1:100, Millipore). After rinsing to remove
the unbound antibodies, samples were exposed to Alexa Fluor® 488
donkey anti-mouse lgG or Alexa Fluor® 594 donkey anti-rabbit lgG
(1:1000, Life Technologies) for 1 h in the dark. Nuclei were counter-
stained with DAPI (1:1000, Sigma). BCIP/NBT Kit (Invitrogen) was
used to detect alkaline phosphatase activity of hESC colonies. All
the images were taken by epiﬂuorescencemicroscopy (Nikon Eclipse
TE2000-U).
Karyotype analysis
The chHES-427 cells cultured on matrigel (BD) with mTeSR1 (Stem
Cell) were treated with 0.1 μg/mL KaryoMAX® Colcemid™ solution
(GIBCO) for 3 h 15 min and harvested with Accutase (Millipore). After
hypotonic treatment with 75 mM KCl solution, cells were ﬁxed with
mixed solution of methanol and acetic acid (3:1), and then sent for
standard G-banding karyotype analysis.
In vitro differentiation
The differentiation ability of chHES-427 cells was evaluated by
in vitro embryoid bodies formation. Undifferentiated cell colonies
were cut into small clumps and detached for suspension culture in ES
medium without bFGF. After 14 days, the embryoid bodies were trans-
ferred to the matrigel-plated dishes for additional adherent culture of
7 days. Differentiated cells were ﬁxed and immunostained with three
germ layermarker (Ectoderm: TUJ1;mesoderm: SMA; endoderm:AFP).
Flow cytometry analysis
The chHES-427 cells were dissociated into single cell with Accutase,
then ﬁxed and permeabilized with Cytoﬁx/Cytoperm buffer (BD) for
20 min at 4 °C. Cell samples were exposed to primary antibodies such
as rabbit anti-NANOG (1:50, Abcam) for 30 min, and then washed
with Perm/Wash buffer (BD) to remove unbound antibodies. Samples
were further combined to Alexa Fluor® 488 donkey anti-rabbit lgG
(1:1000, Life Technologies). Stained cells were analyzed using Accuri
C6 (BD) and Accuri CFlow software.
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Karyotyping and PCR-RFLP analysiswere performed at Reproductive
& Genetic Hospital of CITIC-Xiangya. Twenty metaphase cells were
observed and all had a normal karyotype of 46, XX. The results of PCR-
RFLP assay conﬁrmed a homozygous deletion of SMN1 exon 7 in
chHES-427 cells.
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